Non-infected babies born to HIV mothers have reduced immunity to measles

October 18, 2012, Wiley

Non-infected babies born to HIV positive mothers should be vaccinated early against measles, to avoid them acquiring the virus or passing it on to others.

A study published in the November issue of Acta Paediatrica found that even if babies are born without HIV, their maternally derived protection against measles may be impaired by their mother's positive .

"The eradication of measles is high on the agendas of the and other international agencies and it is important to define and target any new group of susceptible infants" says Dr Lars Smedman from the Department of Paediatrics at Karolinska University Hospital, Stockholm, Sweden.

According to the World Health Organization, measles is one of the leading causes of death among young children. Complications of this highly contagious, serious disease can include , blindness, destructive ear infections, severe diarrhoea and related dehydration.

In 2010 there were 139,300 deaths globally, which equates to 380 a day or 15 an hour. However, in 1980, before widespread immunisation, measles caused an estimated 2.6 million deaths a year. Immunisations have risen by 72% since 2000 and in 2010 about 85 per cent of the World's children received one dose of the by their first birthday.

Dr Smedman and colleagues compared samples from ten babies aged one to four months who were born to HIV mothers, but had not acquired the infection, to ten healthy babies born to mothers without HIV.

The mothers ranged from 26 to 35 years of age, were all immigrants and originated from Ethiopia, the Ivory Coast, Uganda, Kenya and Thailand. Their ranged from less than 20 to 8,870 and their CD4 cell counts from 237 to 754.

Nine gave birth by planned or emergency caesarean, with only one , and the of the babies ranged from 32 to 41 weeks.

"We used a new cell ELISA technique to demonstrate how the serum samples drawn from the infants would inactivate the measles virus" explains Dr Smedman.

"This found statistically significant differences between the maternal antibodies received by the two sets of babies and showed that the non-infected babies born to HIV positive mothers had weaker protection. This was because the antibodies normally produced by the mother to help protect her baby from measles had lost their sharp edge due to her HIV positive status.

"The results suggest that babies born to HIV mothers would not be able to neutralise the measles virus as effectively and would loose protection sooner than babies born to healthy mothers. These babies would therefore be much more likely to succumb to measles and, or, pass the virus on to other children, making their early immunisation vital."

Explore further: South Africa reports new success in saving newborns from HIV

More information: onlinelibrary.wiley.com/doi/10 … 012.02793.x/abstract

Related Stories

South Africa reports new success in saving newborns from HIV

July 19, 2012
About 117,000 babies were saved from HIV infection last year under South Africa's scheme to prevent mothers from passing on the disease during childbirth, health official said Thursday.

Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission

June 20, 2012
Non-breastfed babies born to HIV-positive mothers who didn't receive antiretroviral therapy during pregnancy are routinely given zidovudine, commonly known as AZT, shortly after birth to prevent mother-to-child transmission ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.